EWS-Fli1 Up-Regulates Expression of the Aurora A and Aurora B Kinases

被引:36
作者
Wakahara, Kazuhiko [1 ]
Ohno, Takatoshi [1 ]
Kimura, Masashi [2 ]
Masuda, Takahiro [1 ]
Nozawa, Satoshi [1 ]
Dohjima, Taikoh [1 ]
Yamamoto, Takatoshi [1 ]
Nagano, Akihito [1 ]
Kawai, Gou [1 ]
Matsuhashi, Aya [1 ]
Saitoh, Mitsuru [1 ]
Takigami, Iori [1 ]
Okano, Yukio [2 ]
Shimizu, Katsuji [1 ]
机构
[1] Gifu Univ, Grad Sch Med, Dept Orthopaed Surg, Gifu 5011194, Japan
[2] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu 5011194, Japan
关键词
D O I
10.1158/1541-7786.MCR-08-0054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EWS-Fli1, a fusion gene resulting from the chromosomal translocation t(11;22, q24;q12), encodes a transcriptional activator, promotes cellular transformation, and is often found in Ewing sarcoma and primitive neuroectodermal tumor. The Aurora A and Aurora B kinases belong to a highly conserved family of serine/threonine protein kinases, are tightly regulated during the cell cycle, and are overexpressed in many carcinomas. Because the relationship between the Aurora A and/or Aurora B genes and the EWS-Fli1 fusion gene is unknown, we investigated the regulatory mechanism(s) by which Aurora kinases are controlled. Knockdown of EWS-Fli1 by small interfering RNA reduced mRNA levels not only of EWS-Fli1 but also of Aurora A and Aurora B. Luciferase assay using Aurora A and Aurora B promoters showed up-regulated activities compared with those of an empty vector. Experiments with deletion and point mutants showed positive regulatory Ets-binding sites located -84 and -71 by upstream of the transcription initiation sites in Aurora A and Aurora B, respectively. Moreover, chromatin immunoprecipitation assay revealed that EWS-Fli1 gene products interact with both the Aurora A and Aurora B promoters. These results strongly suggest that the mitotic kinases Aurora A and Aurora B are regulated by EWS-Fli1 fusion protein in Ewing sarcoma cells. (Mol Cancer Res 2008;6(12):1937-45)
引用
收藏
页码:1937 / 1945
页数:9
相关论文
共 57 条
[1]   PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis [J].
Abaan, OD ;
Levenson, A ;
Khan, O ;
Furth, PA ;
Üren, A ;
Toretsky, JA .
ONCOGENE, 2005, 24 (16) :2715-2722
[2]   Biology of EWS/ETS fusions in Ewing's family tumors [J].
Arvand, A ;
Denny, CT .
ONCOGENE, 2001, 20 (40) :5747-5754
[3]  
Arvand A, 2001, CANCER RES, V61, P5311
[4]   A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers [J].
Bischoff, JR ;
Anderson, L ;
Zhu, YF ;
Mossie, K ;
Ng, L ;
Souza, B ;
Schryver, B ;
Flanagan, P ;
Clairvoyant, F ;
Ginther, C ;
Chan, CSM ;
Novotny, M ;
Slamon, DJ ;
Plowman, GD .
EMBO JOURNAL, 1998, 17 (11) :3052-3065
[5]   Aurora kinases: New targets for cancer therapy [J].
Carvajal, Richard D. ;
Tse, Archie ;
Schwartz, Gary K. .
CLINICAL CANCER RESEARCH, 2006, 12 (23) :6869-6875
[6]   Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians [J].
Chen, Jinyun ;
Li, Donghui ;
Wei, Chongjuan ;
Sen, Subrata ;
Killary, Ann M. ;
Amos, Christopher I. ;
Evans, Douglas B. ;
Abbruzzese, James L. ;
Frazier, Marsha L. .
CLINICAL CANCER RESEARCH, 2007, 13 (10) :3100-3104
[7]   Re: Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques [J].
Coleman, N ;
Roberts, I .
CANCER GENETICS AND CYTOGENETICS, 2004, 148 (01) :86-86
[8]   Analysis of the expression of cell cycle regulators in Ewing cell lines:: EWS-FLI-1 modulates p57KIP2 and c-Myc expression [J].
Dauphinot, L ;
De Oliveira, C ;
Melot, T ;
Sevenet, N ;
Thomas, V ;
Weissman, BE ;
Delattre, O .
ONCOGENE, 2001, 20 (25) :3258-3265
[9]  
Deneen B, 2003, CANCER RES, V63, P4268
[10]   Small interfering RNAs expressed from a pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line [J].
Dohjima, T ;
Lee, NS ;
Li, HT ;
Ohno, T ;
Rossi, JJ .
MOLECULAR THERAPY, 2003, 7 (06) :811-816